Czy obniżać ciśnienie tętnicze w ostrej fazie udaru mózgu? – wyniki badania SCAST

Else Charlotte Sandset i wsp – The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial Lancet, Early Online Publication

Interpretation: There was no indication that careful blood-pressure lowering treatment with the angiotensin-receptor blocker candesartan is beneficial in patients with acute stroke and raised blood pressure. If anything, the evidence suggested a harmful effect.

Opracowane na podstawie: Lancet, Early Online Publication / 11 lutego 2011